(Allergan plc)

	AGN latest price $145.4200 (1.3%) ($144.0200 - $147.3000) on Tue. Apr. 16, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.92% (three month average)
RSI	46
Latest Price	$145.4200(1.3%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -0.7% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Value stock rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(49%)    XLV(48%)    ARKG(47%)    XBI(47%)    DIA(45%)
Factors Impacting AGN price	AGN will decline at least -0.96% in a week (0% probabilities).   VIXM(-25%)    UUP(-24%)    TLT(-23%)    IFRA(-17%)    VXX(-14%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.96% (StdDev 1.92%)
Hourly BBV	0 ()
Intraday Trend	0.5%

1 - 5 Day Possible Target	$143.36(-1.42%)
Resistance Level	$147.61
5 Day Moving Average	$145.01(0.28%)
10 Day Moving Average	$146.68(-0.86%)
20 Day Moving Average	$147.61(-1.48%)
To recent high	-9.1%
To recent low	10.7%
Market Cap	$47.945b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed